BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10927841)

  • 1. Fulminant hepatitis A in patients with chronic liver disease.
    Lefilliatre P; Villeneuve JP
    Can J Public Health; 2000; 91(3):168-70. PubMed ID: 10927841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.
    Vento S; Garofano T; Renzini C; Cainelli F; Casali F; Ghironzi G; Ferraro T; Concia E
    N Engl J Med; 1998 Jan; 338(5):286-90. PubMed ID: 9445408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.
    Vento S
    J Viral Hepat; 2000 May; 7 Suppl 1():7-8. PubMed ID: 10866837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hepatitis A and acquired immunity to hepatitis A virus in hepatitis B virus (HBV) carriers and in HBV- or hepatitis C virus-related chronic liver diseases in Thailand.
    Pramoolsinsap C
    J Viral Hepat; 2000 May; 7 Suppl 1():11-2. PubMed ID: 10866839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiological investigation of fatal liver failure during the course of chronic hepatitis B in southeast China.
    Ke WM; Li XJ; Yu LN; Lai J; Li XH; Gao ZL; Chen PJ
    J Gastroenterol; 2006 Apr; 41(4):347-51. PubMed ID: 16741614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence and incidence of hepatitis A in patients with hepatitis B and C].
    Olivé G; Buti M; Ignacio Esteban J; Cotrina M; Esteban R; Guardia J
    Med Clin (Barc); 2000 Sep; 115(7):254-5. PubMed ID: 11013148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: missed opportunities for vaccination.
    Shim M; Khaykis I; Park J; Bini EJ
    Hepatology; 2005 Sep; 42(3):688-95. PubMed ID: 16104047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: hepatitis vaccination in patients with chronic liver disease.
    Reiss G; Keeffe EB
    Aliment Pharmacol Ther; 2004 Apr; 19(7):715-27. PubMed ID: 15043512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination for hepatitis A virus is not required for patients with chronic liver disease in India.
    Acharya SK; Batra Y; Saraya A; Hazari S; Dixit R; Kaur K; Bhatkal B; Ojha B; Panda SK
    Natl Med J India; 2002; 15(5):267-8. PubMed ID: 12502138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need for hepatitis A prevention in patients with chronic liver disease in the changing epidemiological setting of India.
    Raju B; Andani A; Kolhapure S; Agrawal A
    Hum Vaccin Immunother; 2021 May; 17(5):1520-1529. PubMed ID: 33236963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver?
    Duseja A; Sharma S; Das K; Dhiman RK; Chawla YK
    Trop Gastroenterol; 2004; 25(4):162-3. PubMed ID: 15912973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
    Myers RP; Gregor JC; Marotta PJ
    Hepatology; 2000 Apr; 31(4):834-9. PubMed ID: 10733536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis A infection in patients with chronic viral liver disease: a cross-sectional study in Jahrom, Iran.
    Ahmadi Vasmehjani A; Javeshghani D; Baharlou R; Shayestehpour M; Mousavinasab SD; Joharinia N; Enderami SE
    Epidemiol Infect; 2015 Feb; 143(3):534-9. PubMed ID: 24742346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute, hepatitis-A super-infection in HBV carriers, or chronic liver disease related to HBV or HCV.
    Pramoolsinsap C; Poovorawan Y; Hirsch P; Busagorn N; Attamasirikul K
    Ann Trop Med Parasitol; 1999 Oct; 93(7):745-51. PubMed ID: 10715703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
    Koff RS
    J Clin Gastroenterol; 2001 Jul; 33(1):20-6. PubMed ID: 11418785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination for HAV: A Lesson From Acute Hepatitis A Superinfection on Chronic B Hepatitis With Lifesaving Living Donor Liver Transplantation for Hepatic Failure.
    Lin SH; Lin MT; Wang CC; Chen CL; Hu TH; Chiu KW
    Transplantation; 2022 Feb; 106(2):e163-e164. PubMed ID: 35100226
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute viral hepatitis types E, A, and B singly and in combination in acute liver failure in children in north India.
    Arora NK; Nanda SK; Gulati S; Ansari IH; Chawla MK; Gupta SD; Panda SK
    J Med Virol; 1996 Mar; 48(3):215-21. PubMed ID: 8801280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant hepatitis A in indigenous children in north Queensland.
    Hanna JN; Warnock TH; Shepherd RW; Selvey LA
    Med J Aust; 2000 Jan; 172(1):19-21. PubMed ID: 10682011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.